Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2022-10-31 2022-10-17
Drug Identification Number 02327813 02327813
Brand name GALLIUM (GA67) CITRATE INJECTION GALLIUM (GA67) CITRATE INJECTION
Common or Proper name gallium Ga-67 citrate injection gallium Ga-67 citrate injection
Company Name CURIUM CANADA INC CURIUM CANADA INC
Ingredients GALLIUM CITRATE GA 67 GALLIUM CITRATE GA 67
Strength(s) 74MBq 74MBq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 6 & 12 mCi 6 & 12 mCi
ATC code V09HX V09HX
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-10-07 2022-10-07
Actual start date 2022-10-07 2022-10-07
Estimated end date 2022-11-06 Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Curium will continue to supply its customers with no disruption. Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Curium will continue to supply its customers with no disruption.
Health Canada comments